MagDI Australia Study
NCT: NCT06473831 · COMPLETED
広告
NCT識別子NCT06473831
ステータスCOMPLETED
開始日2024-08-13
完了2026-06-25
SponsorGT Metabolic Solutions, Inc. (INDUSTRY)
First posted
Last updated
概要
The objective of the MagDI Australia Study is to evaluate the feasibility / performance, safety, and initial efficacy of the MagDI System in eligible participants who are indicated for a duodeno-ileal (small bowel) side-to-side anastomosis procedure for partial intestinal diversion (e.g., one example of a small bowel clinical procedure requiring a side-to-side anastomosis).
公式ソース
ClinicalTrials.govで見る →データはClinicalTrials.gov APIから取得しています。最新のステータスは公式記録をご確認ください。